Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Trial of Intravenous Immune Globulin in Dermatomyositis.
N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912.
N Engl J Med. 2022.
PMID: 36198179
Clinical Trial.
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Beckmann I, Clodi E, Levine T; ProDERM investigators.
Aggarwal R, et al. Among authors: clodi e.
Arthritis Res Ther. 2024 Jan 17;26(1):27. doi: 10.1186/s13075-023-03232-2.
Arthritis Res Ther. 2024.
PMID: 38233885
Free PMC article.
Clinical Trial.
Item in Clipboard
Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy.
Cornblath DR, van Doorn PA, Hartung HP, Merkies ISJ, Katzberg HD, Hinterberger D, Clodi E; ProCID Investigators.
Cornblath DR, et al. Among authors: clodi e.
Brain. 2022 Apr 29;145(3):887-896. doi: 10.1093/brain/awab422.
Brain. 2022.
PMID: 35038723
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study.
Cornblath DR, van Doorn PA, Hartung HP, Merkies ISJ, Katzberg HD, Hinterberger D, Clodi E; ProCID Investigators.
Cornblath DR, et al. Among authors: clodi e.
Drug Saf. 2023 Sep;46(9):835-845. doi: 10.1007/s40264-023-01326-z. Epub 2023 Jun 28.
Drug Saf. 2023.
PMID: 37378806
Free PMC article.
Clinical Trial.
Item in Clipboard
Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]).
Kobayashi RH, Mandujano JF, Rehman SM, Kobayashi AL, Geng B, Atkinson TP, Melamed I, Turpel-Kantor E, Clodi E, Gupta S.
Kobayashi RH, et al. Among authors: clodi e.
Immunotherapy. 2021 Jul;13(10):813-824. doi: 10.2217/imt-2021-0064. Epub 2021 May 6.
Immunotherapy. 2021.
PMID: 33955240
Free article.
Clinical Trial.
Item in Clipboard
The antibiotic viomycin as a model peptide for the origin of the co-evolution of RNA and proteins.
Wank H, Clodi E, Wallis MG, Schroeder R.
Wank H, et al. Among authors: clodi e.
Orig Life Evol Biosph. 1999 Aug;29(4):391-404. doi: 10.1023/a:1006572028643.
Orig Life Evol Biosph. 1999.
PMID: 10472628
Item in Clipboard
In vitro selection of a viomycin-binding RNA pseudoknot.
Wallis MG, Streicher B, Wank H, von Ahsen U, Clodi E, Wallace ST, Famulok M, Schroeder R.
Wallis MG, et al. Among authors: clodi e.
Chem Biol. 1997 May;4(5):357-66. doi: 10.1016/s1074-5521(97)90126-5.
Chem Biol. 1997.
PMID: 9195872
Item in Clipboard
Assaying RNA chaperone activity in vivo using a novel RNA folding trap.
Clodi E, Semrad K, Schroeder R.
Clodi E, et al.
EMBO J. 1999 Jul 1;18(13):3776-82. doi: 10.1093/emboj/18.13.3776.
EMBO J. 1999.
PMID: 10393192
Free PMC article.
Item in Clipboard
Cite
Cite